Dowling & Yahnke LLC Statera Biopharma, Inc. Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Statera Biopharma, Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 28,875 shares of STAB stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,875
Previous 28,875
-0.0%
Holding current value
$0
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STAB
# of Institutions
4Shares Held
30KCall Options Held
0Put Options Held
0About Statera Biopharma, Inc.
- Ticker STAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,295,700
- Description
- Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...